Pedro Mondejar López-rekin lankidetzan egindako argitalpenak (22)

2023

  1. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

    Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231

  2. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

  3. Incidence and Prevalence of Children's Diffuse Lung Disease in Spain

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 22-29

2021

  1. COVID-19 vaccine prioritisation for people with cystic fibrosis

    Journal of Cystic Fibrosis

  2. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

    Journal of Cystic Fibrosis, Vol. 20, Núm. 1, pp. 25-30

  3. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

    Journal of Cystic Fibrosis, Vol. 20, Núm. 4, pp. 566-577

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  2. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 19, Núm. 6, pp. 868-871

2017

  1. Cystic fibrosis treatment: targeting the basic defect

    Expert Opinion on Orphan Drugs, Vol. 5, Núm. 2, pp. 181-192

  2. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series

    Journal of Medical Case Reports, Vol. 11, Núm. 1

2016

  1. Seguimiento a largo plazo de un programa de prevención y cesación tabáquica en pacientes con fibrosis quística

    Adicciones: Revista de socidrogalcohol, Vol. 28, Núm. 2, pp. 99-107

2015

  1. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life

    Pediatric Allergy and Immunology, Vol. 26, Núm. 8, pp. 797-804

2014

  1. Broncoscopia flexible en el estudio del reflujo gastroesofágico

    Broncoscopia pediátrica y técnicas asociadas (Ergon), pp. 197-206

2013

  1. HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

    Microbiology and Immunology, Vol. 57, Núm. 3, pp. 193-197

2012

  1. Lung function among infants born preterm, with or without bronchopulmonary dysplasia

    Pediatric Pulmonology, Vol. 47, Núm. 7, pp. 674-681

  2. Smoking prevention and cessation programme in cystic fibrosis: Integrating an environmental health approach

    Journal of Cystic Fibrosis, Vol. 11, Núm. 1, pp. 34-39

2010

  1. Do risk factors for persistent asthma modify lung function in infants and young children with recurrent wheeze?

    Pediatric Pulmonology, Vol. 45, Núm. 9, pp. 914-918

2009

  1. CFTR H609R mutation in Ecuadorian patients with cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 8, Núm. 4, pp. 280-281

  2. CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): Implications for genetic testing

    Clinical Genetics